Literature DB >> 26387956

Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice.

Shanshan Huang1, Su Yang2, Jifeng Guo2, Sen Yan3, Marta A Gaertig2, Shihua Li4, Xiao-Jiang Li5.   

Abstract

In polyglutamine (polyQ) diseases, large polyQ repeats cause juvenile cases with different symptoms than those of adult-onset patients, who carry smaller expanded polyQ repeats. The mechanisms behind the differential pathology mediated by different polyQ repeat lengths remain unknown. By studying knockin mouse models of spinal cerebellar ataxia-17 (SCA17), we found that a large polyQ (105 glutamines) in the TATA-box-binding protein (TBP) preferentially causes muscle degeneration and reduces the expression of muscle-specific genes. Direct expression of TBP with different polyQ repeats in mouse muscle revealed that muscle degeneration is mediated only by the large polyQ repeats. Different polyQ repeats differentially alter TBP's interaction with neuronal and muscle-specific transcription factors. As a result, the large polyQ repeat decreases the association of MyoD with TBP and DNA promoters. Our findings suggest that specific alterations in protein interactions by large polyQ repeats may account for the unique pathology in juvenile polyQ diseases.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26387956      PMCID: PMC4598297          DOI: 10.1016/j.celrep.2015.08.060

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  43 in total

1.  In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle.

Authors:  Minenori Ishido; Katsuya Kami; Mitsuhiko Masuhara
Journal:  Am J Physiol Cell Physiol       Date:  2004-04-14       Impact factor: 4.249

Review 2.  Role of MyoD in denervated, disused, and exercised muscle.

Authors:  Kirsten Legerlotz; Heather K Smith
Journal:  Muscle Nerve       Date:  2008-09       Impact factor: 3.217

Review 3.  The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction.

Authors:  F Squitieri; A Ciarmiello; S Di Donato; L Frati
Journal:  Eur J Neurol       Date:  2006-04       Impact factor: 6.089

4.  Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration.

Authors:  Meyer J Friedman; Anjali G Shah; Zhi-Hui Fang; Elizabeth G Ward; Stephen T Warren; Shihua Li; Xiao-Jiang Li
Journal:  Nat Neurosci       Date:  2007-11-11       Impact factor: 24.884

Review 5.  Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.

Authors:  Huda Y Zoghbi; Harry T Orr
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

6.  Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity.

Authors:  Meyer J Friedman; Chuan-En Wang; Xiao-Jiang Li; Shihua Li
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

7.  Expression of mRNA for specific fibroblast growth factors associates with that of the myogenic markers MyoD and proliferating cell nuclear antigen in regenerating and overloaded rat plantaris muscle.

Authors:  Y Tanaka; A Yamaguchi; T Fujikawa; K Sakuma; I Morita; K Ishii
Journal:  Acta Physiol (Oxf)       Date:  2008-04-19       Impact factor: 6.311

8.  Switching of the core transcription machinery during myogenesis.

Authors:  Maria Divina E Deato; Robert Tjian
Journal:  Genes Dev       Date:  2007-08-17       Impact factor: 11.361

9.  Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.

Authors:  Janghoo Lim; Juan Crespo-Barreto; Paymaan Jafar-Nejad; Aaron B Bowman; Ronald Richman; David E Hill; Harry T Orr; Huda Y Zoghbi
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

10.  MyoD targets TAF3/TRF3 to activate myogenin transcription.

Authors:  Maria Divina E Deato; Michael T Marr; Theo Sottero; Carla Inouye; Ping Hu; Robert Tjian
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

View more
  20 in total

1.  Role of Mutant TBP in Regulation of Myogenesis on Muscle Satellite Cells.

Authors:  Dong-Ming Zhao; Sui-Qiang Zhu; Fu-Rong Wang; Shan-Shan Huang
Journal:  Curr Med Sci       Date:  2019-10-14

Review 2.  Genetically modified rodent models of SCA17.

Authors:  Yiting Cui; Su Yang; Xiao-Jiang Li; Shihua Li
Journal:  J Neurosci Res       Date:  2016-11-18       Impact factor: 4.164

3.  Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.

Authors:  Yang Yang; Su Yang; Jifeng Guo; Yiting Cui; Beisha Tang; Xiao-Jiang Li; Shihua Li
Journal:  J Neurosci       Date:  2017-08-18       Impact factor: 6.167

4.  The Expanding Clinical Universe of Polyglutamine Disease.

Authors:  Shanshan Huang; Suiqiang Zhu; Xiao-Jiang Li; Shihua Li
Journal:  Neuroscientist       Date:  2019-01-07       Impact factor: 7.519

5.  Molecular mechanisms underlying Spinocerebellar Ataxia 17 (SCA17) pathogenesis.

Authors:  Su Yang; Xiao-Jiang Li; Shihua Li
Journal:  Rare Dis       Date:  2016-08-12

6.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

Review 7.  Skeletal Muscle Pathogenesis in Polyglutamine Diseases.

Authors:  Caterina Marchioretti; Emanuela Zuccaro; Udai Bhan Pandey; Jessica Rosati; Manuela Basso; Maria Pennuto
Journal:  Cells       Date:  2022-07-03       Impact factor: 7.666

8.  Polyglutamine diseases: looking beyond the neurodegenerative universe.

Authors:  Michal Mielcarek; Mark Isalan
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

9.  Real-time imaging of Huntingtin aggregates diverting target search and gene transcription.

Authors:  Li Li; Hui Liu; Peng Dong; Dong Li; Wesley R Legant; Jonathan B Grimm; Luke D Lavis; Eric Betzig; Robert Tjian; Zhe Liu
Journal:  Elife       Date:  2016-08-03       Impact factor: 8.140

10.  A shared mechanism of muscle wasting in cancer and Huntington's disease.

Authors:  Michal Mielcarek; Mark Isalan
Journal:  Clin Transl Med       Date:  2015-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.